Stockreport

Acrivon Therapeutics to Present at the Jefferies Global Healthcare Conference

Acrivon Therapeutics, Inc.  (ACRV) 
PDF WATERTOWN, Mass., May 29, 2024 (GLOBE NEWSWIRE) --  Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biopharmaceutical [Read more]